SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

6 Months Ended

12 Months Ended

Sep. 30, 2025

Mar. 31, 2025

Accounting Policies [Abstract]

SCHEDULE OF REVENUE RECOGNITION

The Company recognized the following forms of revenue for the three and six months ended September 30, 2025, and 2024:

	Three months ended September 30				Six months ended September 30
	2025		2024		2025		2024
	$		$		$		$
Technology fees		3,511,454		3,064,814		6,882,846		6,081,064
Device sales		374,341		202,032		876,942		387,525
		3,885,795		3,266,846		7,759,788		6,468,589

The Company recognized the following forms of revenue for the fiscal years ended March 31, 2025 and 2024:

	2025		2024
	$		$
Technology fees		12,591,036		11,249,113
Device sales		1,199,258		814,232
		13,790,294		12,063,345

SCHEDULE OF INVENTORIES

	September 30, 2025		March 31, 2025
	$		$
Raw material		1,019,042		1,225,665
Finished goods		1,237,247		329,720
		2,256,289		1,555,385

	2025		2024
	$		$
Raw material		1,225,665		1,128,700
Finished goods		329,720		750,702
		1,555,385		1,879,402

SCHEDULE OF FAIR VALUE OF FINANCIAL INSTRUMENTS

The fair value of financial instruments measured on a recurring basis is as follows:

	As of September 30, 2025
Description	Total		Level 1		Level 2		Level 3
Assets:
Total assets at fair value	$	—		—	$	—	$	—
Liabilities:
Derivative liabilities, short-term	$	443,583	$	—	$	—	$	443,583
Derivative liabilities, long-term		1,382,103		—		—		1,382,103
Total liabilities at fair value	$	1,825,686	$	—	$	—	$	1,825,686

BIOTRICITY INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSSFOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2025 AND 2024 (unaudited) (Expressed in US Dollars)

	As of March 31, 2025
Description	Total		Level 1		Level 2		Level 3
Assets:
Total assets at fair value	$	—	$	—	$	—	$	—
Liabilities:
Derivative liabilities, short-term	$	424,200	$	—	$	—	$	424,200
Derivative liabilities, long-term		1,478,717		—		—		1,478,717
Total liabilities at fair value	$	1,902,917	$	—	$	—	$	1,902,917

The fair value of financial instruments measured on a recurring basis is as follows:

	As of March 31, 2025
Description	Total		Level 1		Level 2		Level 3
Assets:
Cash	$	365,145	$	365,145	$	—	$	—
Total assets at fair value	$	365,145	$	365,145	$	—	$	—
Liabilities:
Derivative liabilities, short-term	$	424,200	$	—	$	—	$	424,200
Derivative liabilities, long-term		1,478,717	$	—	$	—	$	1,478,717
Total liabilities at fair value	$	1,902,917	$	—	$	—	$	1,902,917

	As of March 31, 2024
Description	Total		Level 1		Level 2		Level 3
Assets:
Cash	$	786,060	$	786,060	$	—	$	—
Total assets at fair value	$	786,060	$	786,060	$	—	$	—
Liabilities:
Derivative liabilities, short-term	$	991,866	$	—	$	—	$	991,866
Derivative liabilities, long-term		1,435,668		—		—		1,435,668
Total liabilities at fair value	$	2,427,534	$	—	$	—	$	2,427,534

SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES

Office equipment	5 years
Leasehold improvement	5 years

Office equipment	5 years
Leasehold improvement	5 years